Adamas sets IPO range

CNS company Adamas Pharmaceuticals Inc. (Emeryville, Calif.) amended its IPO on NASDAQ and now plans to sell 3 million shares at $16-$18. At the $17 midpoint, the company would raise $51 million and be valued at $279.3 million. Credit Suisse; Piper Jaffray; William Blair; and Needham are underwriters. ...